1. In Arrayed Ranks: Array Technology in the Study of Mesothelioma
Steven G. Gray, PhD, Dean A. Fennell, MD, PhD, Luciano Mutti, MD, PhD, Kenneth J. O’Byrne, MD, PhD 
Journal of Thoracic Oncology 
Volume 4, Issue 3, Pages (March 2009)
DOI: /JTO.0b013e ce8
Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

2. FIGURE 1
Graphical comparison of five microarray studies of malignant pleural mesothelioma (MPM)60–62,64,65 with prognostic gene lists. Adapted with permission from López-Ríos F, Chuai S, Flores R, Shimizu S, Ohno T, Wakahara K, Illei PB, Hussain S, Krug L, Zakowski MF, Rusch V, Olshen AB, Ladanyi M. Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction. HYPERLINK “javascript:AL_get(this,%20'jour’,%20’Cancer%20Res.’);” Cancer Res Mar 15;66(6):2970–9, Figure 3.
Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e ce8)
Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions